Clinical Trial Update: Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

View source ↗

Summary

A completed multi-country post-marketing observational study assessing the maintenance of effectiveness of adalimumab (Humira) in Ankylosing Spondylitis and Pso…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Psoriatic Arthritis

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Ankylosing Spondylitis, Psoriatic Arthritis | Status: COMPLETED | Results posted: 2015-07-08